Endurant Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $243K | Sell |
|
|||||
|
2023
Q2 | $759K | Sell |
|
|||||
|
2023
Q1 | $1.81M | Sell |
|
|||||
|
2022
Q4 | $2.53M | Sell |
|
|||||
|
2022
Q3 | $1.92M | Sell |
|
|||||
|
2022
Q2 | $3.1M | Sell |
|
|||||
|
2022
Q1 | $4.45M | Buy |
|
|||||
|
2021
Q4 | $3.37M | Sell |
|
|||||
|
2021
Q3 | $4.74M | Sell |
|
|||||
|
2021
Q2 | $6.56M | Buy |
|
|||||
|
2021
Q1 | $4.86M | Sell |
|
|||||
|
2020
Q4 | $5.81M | Buy |
|
|||||
|
2020
Q3 | $4.58M | Buy |
|
|||||
|
2020
Q2 | $4.84M | Buy |
|
|||||
|
2020
Q1 | $435K | Buy |
|